Eurofins Scientific revenue and financials
€76.10Change from previous close: −0.05%Absolute change: −€0.04
In the fiscal year ended December 2025, Eurofins Scientific reported revenue of €7.3B (+4.96% year over year). Net income was €474.8M, a net margin of 6.5%.
Fiscal year ending in December. Sources and method on the page Methodology and sources.
At a glance
- Revenue growth
- +4.96%
- 2025 vs 2024
- Net income growth
- +16.83%
- 2025 vs 2024
- Net margin
- 6.5%
- 2024: 5.8%
Financial data
Amounts in millions of EUR; per-share values in EUR; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | 10,985 | 10,888 | 10,889 | 10,084 | — |
| Current assets | 2,654 | 2,452 | 3,066 | 2,313 | — |
| Cash and equivalents | 791 | 614 | 1,221 | 487 | — |
| Inventory | 139 | 142 | 139 | 146 | — |
| Net property, plant and equipment | 2,763 | 2,560 | 2,297 | 2,168 | — |
| Goodwill | 4,657 | 4,841 | 4,551 | 4,524 | — |
| Other intangible assets | 690 | 788 | 796 | 919 | — |
| Long-term investments | 5.3 | 5.9 | 5.3 | 5.2 | — |
| Current liabilities | 2,430 | 2,110 | 2,122 | 1,772 | — |
| Accounts payable | 678 | 646 | 600 | 648 | — |
| Long-term debt | 3,407 | 2,674 | 2,889 | 2,713 | — |
| Total debt | 4,432 | 3,610 | 3,927 | 3,326 | — |
| Total liabilities | 6,409 | 5,504 | 5,751 | 5,233 | — |
| Total equity (incl. minority) | 4,577 | 5,385 | 5,137 | 4,851 | — |
| Retained earnings | 3,024 | 2,692 | 2,394 | 2,333 | — |
| Minority interest | 33.4 | 45.8 | 59.9 | 68.9 | — |